Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer

Go back to Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer
(NASDAQ: IMUX) Delayed: 16.50 +0.40 (2.48%)
Previous Close $16.10    52 Week High
Open $16.22    52 Week Low
Day High $16.83    P/E N/A 
Day Low $16.20    EPS
Volume 147,690